Latest News

Aroa Biosurgery acquires Endoform business from Hollister12 Apr 2018

Auckland, April 12, 2018: New Zealand biomedical company Aroa Biosurgery has bought back the global marketing and distribution business for its Endoform wound care solutions after US healthcare company Hollister Incorporated decided to divest portions of its wound care business.

Continue Reading

FDA 510(k) Clearance for Endoform® Silver Dermal Template24 Nov 2017

Aroa Biosurgery has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for the company’s Endoform® Silver Dermal Template, which allows the company to market and sell this device in the USA.

Continue Reading

Big investment in Aroa Biosurgery‘s Commercial Partner30 Oct 2017

New Zealand biomedical company Aroa Biosurgery faces accelerating growth after a significant investment of up to US$25 million in its surgical partner for commercial expansion.

Continue Reading
1234Next ›